Research Project

Project Title:

RTX4 Trial

Project Type:

Clinical Trial, Enrolment ongoing

Disease group(s):

Hereditary glomerulopathies

Project Summary:

Efficacy of humanized chimeric monoclonal anti-CD20 antibodies (Rituximab Biosimilar) in the treatment of childhood steroid-dependent nephrotic syndrome and development of cell biomarkers predicting outcome.

Lead principal investigator(s):

Gian Marco Ghiggeri, Genova

Co-investigator(s):

Marina Vivarelli, Rome
Francesco Emma, Rome

Project Period:

06/2019   -   06/2023

Sponsors:

National funding agency

EudraCT Nr.:

2018-001042-33

« Back to research page